Protect Your Trading Account With Options!
This might be the opposite of what you’ve heard, but the real risk in the market now lies with stock trading… “Options Trading Made Easy” by expert Chuck Hughes will show you how the nature of options trading gives you the chance to profit no matter which way the market trends!

Get the e-book today!
>>>
Jonathan W. Ayers, insider at IDEXX Laboratories

Jonathan W. Ayers Insider Information

Director of IDEXX Laboratories
Mr. Ayers has served as Senior Advisor to the Company since November 2019. Prior to that, Mr. Ayers served as the Chair of the Board from January 2002 to November 2019 and served as President and Chief Executive Officer of IDEXX from January 2002 to June 2019. Before joining IDEXX, Mr. Ayers held various executive leadership positions at United Technologies Corporation and its business unit Carrier Corporation from 1995 - 2001. Prior to that, Mr. Ayers held various investment banking positions at Morgan Stanley & Co. for nine years. Mr. Ayers holds an undergraduate degree in molecular biophysics and biochemistry from Yale University and an MBA from Harvard Business School, with high distinction.

What is Jonathan W. Ayers' net worth?

The estimated net worth of Jonathan W. Ayers is at least $231.09 million as of May 28th, 2021. Mr. Ayers owns 644,701 shares of IDEXX Laboratories stock worth more than $231,086,626 as of July 3rd. This net worth evaluation does not reflect any other investments that Mr. Ayers may own. Learn More about Jonathan W. Ayers' net worth.

How do I contact Jonathan W. Ayers?

The corporate mailing address for Mr. Ayers and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected] Learn More on Jonathan W. Ayers' contact information.

Has Jonathan W. Ayers been buying or selling shares of IDEXX Laboratories?

Jonathan W. Ayers has not been actively trading shares of IDEXX Laboratories during the past quarter. As far as recent transactions, 0 shares of the stock in a transaction that occurred on Sunday, July 3rd. Learn More on Jonathan W. Ayers' trading history.

Who are IDEXX Laboratories' active insiders?

IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Bruce Claflin (Director), Rebecca Henderson (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Jonathan Mazelsky (CEO), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), Giovani Twigge (SVP), and Sophie Vandebroek (Director). Learn More on IDEXX Laboratories' active insiders.

Are insiders buying or selling shares of IDEXX Laboratories?

During the last year, insiders at the sold shares 10 times. They sold a total of 38,041 shares worth more than $25,659,642.09. The most recent insider tranaction occured on February, 15th when Director Jonathan W Ayers sold 250 shares worth more than $127,425.00. Insiders at IDEXX Laboratories own 2.1 % of the company. Learn More about insider trades at IDEXX Laboratories.

Information on this page was last updated on 2/15/2022.

Jonathan W. Ayers Insider Trading History at IDEXX Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/15/2022Sell250$509.70$127,425.00View SEC Filing Icon  
5/28/2021Sell9,460$562.26$5,318,979.60644,701View SEC Filing Icon  
5/25/2021Sell5,000$552.17$2,760,850.00658,701View SEC Filing Icon  
5/18/2021Sell7,632$528.01$4,029,772.32661,333View SEC Filing Icon  
5/10/2021Sell512$541.02$277,002.24653,703View SEC Filing Icon  
2/18/2021Sell1,000$555.56$555,560.00652,737View SEC Filing Icon  
11/6/2020Sell6,470$470.01$3,040,964.70716,178View SEC Filing Icon  
11/4/2020Sell11,440$471.90$5,398,536.00742,535View SEC Filing Icon  
5/11/2020Sell20,000$297.80$5,956,000.00810,467View SEC Filing Icon  
5/8/2020Sell21,130$291.63$6,162,141.90831,597View SEC Filing Icon  
5/6/2020Sell13,600$286.07$3,890,552.00810,467View SEC Filing Icon  
2/19/2020Sell39,143$293.62$11,493,167.66847,983View SEC Filing Icon  
2/14/2020Sell200$383.44$76,688.00835,467View SEC Filing Icon  
11/12/2019Sell36,000$254.05$9,145,800.00947,317View SEC Filing Icon  
11/4/2019Sell62,097$279.57$17,360,458.29View SEC Filing Icon  
8/8/2019Sell10,000$272.75$2,727,500.001,035,942View SEC Filing Icon  
8/6/2019Sell20,000$262.26$5,245,200.00View SEC Filing Icon  
5/3/2019Sell28,000$249.02$6,972,560.00View SEC Filing Icon  
2/6/2019Sell15,905$208.13$3,310,307.651,047,226View SEC Filing Icon  
8/23/2018Sell30,000$245.50$7,365,000.00View SEC Filing Icon  
8/23/2018Sell7,000$247.33$1,731,310.00View SEC Filing Icon  
8/21/2018Sell7,000$243.20$1,702,400.00View SEC Filing Icon  
2/8/2018Sell22,000$177.52$3,905,440.001,077,112View SEC Filing Icon  
2/6/2018Sell36,000$179.28$6,454,080.001,077,112View SEC Filing Icon  
1/11/2018Sell2,160$167.03$360,784.801,077,112View SEC Filing Icon  
1/9/2018Sell18,000$165.15$2,972,700.001,077,112View SEC Filing Icon  
11/16/2017Sell18,000$153.61$2,764,980.001,064,573View SEC Filing Icon  
11/14/2017Sell18,000$148.35$2,670,300.001,064,573View SEC Filing Icon  
11/7/2017Sell54,000$151.32$8,171,280.001,064,573View SEC Filing Icon  
11/3/2017Sell18,000$153.75$2,767,500.001,064,573View SEC Filing Icon  
8/28/2017Sell13,000$150.79$1,960,270.001,044,034View SEC Filing Icon  
8/16/2017Sell58,000$155.00$8,990,000.001,043,034View SEC Filing Icon  
8/15/2017Sell20,000$154.62$3,092,400.001,043,034View SEC Filing Icon  
8/14/2017Sell18,000$154.91$2,788,380.001,043,034View SEC Filing Icon  
8/9/2017Sell17,000$154.54$2,627,180.001,039,034View SEC Filing Icon  
8/8/2017Sell18,000$155.22$2,793,960.00View SEC Filing Icon  
5/30/2017Sell13,000$167.82$2,181,660.001,032,994View SEC Filing Icon  
5/10/2017Sell27,000$162.69$4,392,630.001,024,994View SEC Filing Icon  
5/5/2017Sell26,000$160.61$4,175,860.00View SEC Filing Icon  
2/22/2017Sell35,000$142.58$4,990,300.00995,947View SEC Filing Icon  
2/8/2017Sell36,250$141.63$5,134,087.50View SEC Filing Icon  
11/29/2016Sell27,424$119.77$3,284,572.481,001,043View SEC Filing Icon  
11/28/2016Sell13,188$119.57$1,576,889.161,001,043View SEC Filing Icon  
11/9/2016Sell40,000$107.85$4,314,000.00View SEC Filing Icon  
8/4/2016Sell60,000$107.69$6,461,400.00View SEC Filing Icon  
8/17/2015Sell14,799$78.45$1,160,981.55View SEC Filing Icon  
2/12/2015Sell58,245$155.45$9,054,185.25View SEC Filing Icon  
1/14/2015Sell28,512$157.68$4,495,772.16View SEC Filing Icon  
12/3/2014Sell29,000$148.49$4,306,210.00View SEC Filing Icon  
11/5/2014Sell29,000$143.45$4,160,050.00View SEC Filing Icon  
10/25/2013Sell78,178$104.36$8,158,656.08View SEC Filing Icon  
11/13/2012Sell15,000$89.92$1,348,800.00View SEC Filing Icon  
See Full Table

Jonathan W. Ayers Buying and Selling Activity at IDEXX Laboratories

This chart shows Jonathan W Ayers's buying and selling at IDEXX Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IDEXX Laboratories Company Overview

IDEXX Laboratories logo
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Read More

Today's Range

Now: $358.44
Low: $348.57
High: $359.53

50 Day Range

MA: $372.07
Low: $327.37
High: $472.27

2 Week Range

Now: $358.44
Low: $318.50
High: $706.95

Volume

369,091 shs

Average Volume

601,575 shs

Market Capitalization

$30.11 billion

P/E Ratio

42.02

Dividend Yield

N/A

Beta

1.12
Protect Your Trading Account With Options!
This might be the opposite of what you’ve heard, but the real risk in the market now lies with stock trading… “Options Trading Made Easy” by expert Chuck Hughes will show you how the nature of options trading gives you the chance to profit no matter which way the market trends!

Get the e-book today!
>>>